US 9682957
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
granted A61KA61K31/444A61K31/4709
Quick answer
US patent 9682957 (Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity) held by Theravance Respiratory Company, LLC expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Respiratory Company, LLC
- Grant date
- Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/444, A61K31/4709, A61K31/56, A61K45/06